Green Cross and Pfizer Korea on strategic alliance for Genotropin.

Published: 2005-08-30 06:59:00

Updated: 2005-08-30 06:59:00

Green Cross agreed a business alliance with Pfizer for the distribution of Genotropin, the top human growth hormone product in the world for the treatment of the small baby for gestational age (SGA), a rare disease called Prader-Willi syndrome (PWS). The product will be launched to the market thi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK